학술논문

Preliminary efficacy, safety, and immunomodulatory effects of PT-112 from a phase 2 proof of concept study in patients (pts) with thymic epithelial tumors (TETs).
Document Type
Article
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe20647-e20647, 1p
Subject
Language
ISSN
0732183X